// App-Quantinova.ai

Filters

Biomarkers











Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























7277 Abstracts

Low Incidence of Stent Thrombosis in Asian Races: Multicenter Registry in Asia 7 Years Follow-Up Result

Sunao Nakamura - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

sirolimus

Multi Center, Prospective, Randomized, Single Blind, Consecutive Enrollment Evaluation Of Elixir DESyneTM Novolimus-Eluting Coronary Stent System With Durable Polymer To Endeavor Zotarolimus-Eluting Coronary Stent System: 3-Year Clinical and 9-Month Angiographic And IVUS Results: EXCELLA II Study

Stefan Verheye - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

ZoMaxx

Trends in Revascularization and Mortality for BMS and DES Coronary Stenting Procedures: A Medicare Study of 156,300 patients

Jasmine Patel - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Seven-year Clinical Outcomes of Sirolimus-Eluting Stent Versus Bare-Metal Stent; A Matched Analysis From A Real World, Single Center Registry

Jin-Sung Lee - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

sirolimus

Profile and Outcome of Very Late Bare Metal Stent Thrombosis Treated With Percutaneous Coronary Intervention

Ivan Gomez Blazquez - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Aspirin

Everolimus Eluting Stents Versus First Generation Drug Eluting Stents (Sirolimus or Paclitaxel) for Treatment of Drug-Eluting Stent In-Stent Restenosis

Sachin Goel - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Everolimus

Incidence and Correlates of Stent Thrombosis up to 10 Years After Drug-Eluting Stent Implantation in Daily Clinical Practice

Ricardo Costa - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Impact of Moderate and Severe Coronary Calcification on 1-Year Outcomes after PCI with DES: A Pooled Analysis of 11,651 Patients from 14 Randomized Trials

Philippe Genereux - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Drug-eluting stents versus bare metal stents for saphenous vein graft lesions: meta-analysis of randomized trials

Alban Dibra - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Tryton-Xience for the Treatment of Complex Coronary Bifurcation Lesions: A Single Center Consecutive Series

Daniela Trabattoni - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Coronary bifurcation angle from 3-D predicts clinical outcomes after stenting bifurcation lesions

Shao Liang Chen - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

N/A

Long Term Outcomes Of Simple And Complex Coronary Bifurcation Lesions (CBL) Treated With Drug Eluting Stents (DES)

Leonard Ngunga - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

The Impact of Side Branch Predilatation on Procedural and Long-term Clinical Outcomes in Coronary Bifurcation Lesions Treated by Provisional Approach: Results from the COBIS (Coronary BIfurcation Stent) Registry

Pil Sang Song - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Treatment of bifurcation lesions with a Drug Eluting Stent with biodegradable polymer

Fazilatum Nesa Malik - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Biolimus A9

Safety and Clinical Efficacy of Sideguard Stent for Treatment of Bifurcation Lesions: Interim Results from the European Sideguard Bifurcation Registry Study

Farzin Fath-Ordoubadi - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

The Feasibility And Safety Of Balloon Dilation Over The Jailed Wire To Reopen The (sub)Occluded Side Branch During Provisional Stenting

li chengxiang - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Two Year Outcomes Following Unprotected Left Main Stenting with First- vs. New-Generation Drug-Eluting Stents: The FINE Registry

Gill Buchanan - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Short and Long Term Clinical Outcomes of Left Main Treatment with a Latest Generation Drug Eluting Stent

Bernard Chevalier - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Crofelemer

A Comparison of Clinical Outcomes in Patients with Left Main Disease Treated with CABG vs Drug Eluting Stents. A Single Center Experience

Costantino Costantini - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Dedicated Bifurcation Optimization Stent System BiOSS in Distal Left Main bifurcation stenosis First-in-Human Results: Data from BIOSS Registry (Poland and Bulgaria)

Dobrin Vassilev - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Paclitaxel

Copyright © 2026. QuantiNova All rights reserved